Merck reported earnings that beat analysts' expectations, but global sales dropped amid patent expirations and a drop in sales of its hep C drugs.» Read More
Marijn Dekkers, Bayer CEO, shares his thoughts on imposing additional sanctions on Russia. I think it's important to sit around the table and come up with diplomatic solutions, says Dekkers.
Marijn Dekkers, Bayer CEO, discusses the details of his company's acquisition of Merck's consumer unit. Bayer can take these products and position them stronger outside the United States, says Dekkers.
The FDA said that people should use daily aspirin therapy only after assessing the benefits and risks.
Merck reported better-than-expected quarterly earnings, helped by cost cuts and asset sales, but revenue came in slightly below expectations.
Some of the names on the move ahead of the open.
Bayer CEO Marijn Dekkers told CNBC he did not feel a need to make acquisitions on Monday.
Marijn Dekkers, CEO of Bayer, says the company does not feel the "absolute need" to make acquisitions, but is keeping an eye on opportunities in the market.
"Smiling from a safe distance" is how German media described China's President Xi Jinping during his press conference last Friday.
European stock markets trimmed last week's gains to close lower on Monday, off the back of weak Chinese data and tensions in Ukraine.
European stocks closed flat on Friday, boosted by economic data from the U.S.
German pharmaceutical group Bayer offered to buy Norway's Algeta for $2.4 billion, Algeta said on Tuesday.
A majority of women are unaware birth control is available for free from health insurance plans under Obamacare, although that right faces court challenges.
We could be witnessing the beginning of a merger wave in biotech, Jim Cramer said Tuesday.
Amgen has struck a $10 billion-plus deal to buy Onyx Pharmaceuticals, ending a two-month-long auction for the cancer drugmaker.
Marijn Dekkers, CEO of drug and chemicals company Bayer, tells CNBC that falling earnings in the material sciences division may make it harder to achieve its earnings goals for the year.
China is preventing a GlaxoSmithKline executive from leaving the country as police accuse the British drugmaker of bribing officials and doctors, the drugmaker says.
A federal judge in Kansas City, Kansas, ordered Dow Chemical Co on Wednesday to pay $1.2 billion in a price-fixing case involving chemicals used to make foam products in cars.
European shares closed higher on Monday after Italy's new Prime Minister announced his reform plans in his maiden speech to parliament.
Germany's Bayer has agreed to buy U.S. contraceptive devices maker Conceptus for $1.1 billion, aiming to underpin its position as the world's largest women's healthcare provider.
Marijn Dekkers, CEO of Bayer, says the positive outlook for 2013 is driven by strong projected strong growth in Healthcare and Crop Sciences and explains how the company is heavily investing in its growth.